Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 43 citing articles:

Bioinformatics Analysis Reveals Biomarkers With Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma
Yi Liao, Hua Xiao, Mengqing Cheng, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 47
LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma
Fahui Liu, Wanyun Hou, Jiadong Liang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 13, pp. 4039-4048
Open Access | Times Cited: 32
CENPL, ISG20L2, LSM4, MRPL3 are four novel hub genes and may serve as diagnostic and prognostic markers in breast cancer
Jinbao Yin, Chen Lin, Meng Jiang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 31
Potential therapeutic targets of the nuclear division cycle 80 (NDC80) complexes genes in lung adenocarcinoma
Zhongyi Sun, Wei Wang, Han Gao, et al.
Journal of Cancer (2020) Vol. 11, Iss. 10, pp. 2921-2934
Open Access | Times Cited: 31
Progressive and Prognostic Performance of an Extracellular Matrix-Receptor Interaction Signature in Gastric Cancer
Xiangchou Yang, Liping Chen, Yuting Mao, et al.
Disease Markers (2020) Vol. 2020, pp. 1-23
Open Access | Times Cited: 30
Tubulin Proteins in Cancer Resistance: A Review
Mohammad Amjad Kamal, Maryam H. Al-Zahrani, Salman Hasan Khan, et al.
Current Drug Metabolism (2020) Vol. 21, Iss. 3, pp. 178-185
Closed Access | Times Cited: 29
In‐depth proteomic analysis reveals unique subtype‐specific signatures in human small‐cell lung cancer
Beáta Szeitz, Zsolt Megyesfalvi, Nicole Woldmar, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 18
Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer
Guojing Zhang, Abbe Pannucci, Andrei A. Ivanov, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 446-446
Open Access
Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma
Xiaohan Ma, Huijun Ren, Ruoyu Peng, et al.
PeerJ (2020) Vol. 8, pp. e9086-e9086
Open Access | Times Cited: 24
Histone demethylase KDM3B regulates the transcriptional network of cell-cycle genes in hepatocarcinoma HepG2 cells
Mi-Jin An, Dae‐Hyun Kim, Chulhong Kim, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 508, Iss. 2, pp. 576-582
Closed Access | Times Cited: 26
Analysis of the Expression of Cell Division Cycle-Associated Genes and Its Prognostic Significance in Human Lung Carcinoma: A Review of the Literature Databases
Chongxiang Chen, Siliang Chen, Lanlan Pang, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 22
Prognostic and clinicopathological value of BUB1B expression in patients with lung adenocarcinoma: a meta-analysis
Jie Chen, Yi Liao, Xianming Fan
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 7, pp. 795-803
Closed Access | Times Cited: 16
Identification of Biomarkers Associated With Paget's Disease of Bone and Bone Metastasis From Breast Cancer Patients
Mahima Bhardwaj, Farhana Begum, Duleswar Singh, et al.
Cancer Reports (2024) Vol. 7, Iss. 9
Open Access | Times Cited: 2
Identification of potential target genes and crucial pathways in small cell lung cancer based on bioinformatic strategy and human samples
Xiuwen Chen, Li Wang, Xiaomin Su, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0242194-e0242194
Open Access | Times Cited: 18
Contrastive learning-based computational histopathology predict differential expression of cancer driver genes
Haojie Huang, Zhou Gong-ming, Xuejun Liu, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 11
Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer
Atsushi Fushimi, Yoshihiro Morimoto, Satoshi Ishikawa, et al.
Molecular Cancer Research (2022) Vol. 20, Iss. 9, pp. 1379-1390
Open Access | Times Cited: 11
Comprehensive analysis of differential expression profiles reveals potential biomarkers associated with the cell cycle and regulated by p53 in human small cell lung cancer
Zhong Ni, Xiting Wang, Tianchen Zhang, et al.
Experimental and Therapeutic Medicine (2018)
Open Access | Times Cited: 18
Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target
Shunsuke Misono, Keiko Mizuno, Takayuki Suetsugu, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1187-1187
Open Access | Times Cited: 14
Identification of differentially expressed genes using microarray analysis and COL6A1 induction of bone metastasis in non‑small cell lung cancer
Nan Li, Ming Liu, Xiaohui Cao, et al.
Oncology Letters (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 11
Two co-inherited SNPs of the telomerase reverse transcriptase (TERT) gene are associated with Iraqi patients with lung cancer
Zahraa Kamil Kadhim Lawi, Ahmed H. Alkhammas, Malek Elerouri, et al.
Journal of Medical Biochemistry (2023) Vol. 42, Iss. 4, pp. 694-705
Open Access | Times Cited: 4
Identification of Immune Infiltration and Prognostic Biomarkers in Small Cell Lung Cancer Based on Bioinformatic Methods from 3 Studies
Changhua Yu, Jiaoyan Cao
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 26, Iss. 3, pp. 507-516
Closed Access | Times Cited: 7
Identification of Six Novel Prognostic Gene Signatures as Potential Biomarkers in Small Cell Lung Cancer
Cailian Wang, Shicheng Feng, Xiuxiu Zhang, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 26, Iss. 5, pp. 938-949
Closed Access | Times Cited: 7
Small cell lung cancer; recent advances of its biology and therapeutic perspective
Ryuji Hayashi, Minehiko Inomata
Respiratory Investigation (2021) Vol. 60, Iss. 2, pp. 197-204
Open Access | Times Cited: 9
High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma
Zhenpeng Zhu, Lanruo Lin, Tongde Lv, et al.
Oncology Reports (2020)
Open Access | Times Cited: 8
The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation
Yi Yin, Dong Li, Muqun He, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 8, pp. 2622-2635
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top